Daniel E Jonas

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint Pharmacogenomic testing and the prospect of individualized treatment
    Daniel E Jonas
    Department of Medicine, University of North Carolina School of Medicine Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Eshelman School Of Pharmacy and Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, 5034 Old Clinic Bldg, CB 7110, Chapel Hill, NC 27599, USA
    N C Med J 74:485-93. 2013
  2. pmc Methods for the drug effectiveness review project
    Marian S McDonagh
    Department of Medical Informatics and Clinical Epidemiology and Evidence based Practice Center, School of Medicine, Oregon Health and Science University, Portland, OR, USA
    BMC Med Res Methodol 12:140. 2012
  3. ncbi request reprint Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
    Daniel E Jonas
    University of North Carolina at Chapel Hill, Department of Medicine, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Ann Intern Med 157:645-54. 2012
  4. doi request reprint Identifying priorities for patient-centered outcomes research for serious mental illness
    Daniel E Jonas
    Department of Medicine, University of North Carolina atChapel Hill, 5039 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Psychiatr Serv 63:1125-30. 2012
  5. pmc Chapter 11: challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators
    Daniel E Jonas
    Department of Medicine, Cecil G Sheps Center for Health Services Research, and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Gen Intern Med 27:S83-93. 2012
  6. doi request reprint Patient time requirements for anticoagulation therapy with warfarin
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, USA
    Med Decis Making 30:206-16. 2010
  7. doi request reprint Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
    Health Econ 19:1193-211. 2010
  8. doi request reprint Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study
    Daniel E Jonas
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Med Decis Making 28:56-65. 2008
  9. doi request reprint Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis
    Lea C Watson
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Prim Care Community Health 4:294-306. 2013
  10. ncbi request reprint Patient time requirements for screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 102:2401-10. 2007

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Pharmacogenomic testing and the prospect of individualized treatment
    Daniel E Jonas
    Department of Medicine, University of North Carolina School of Medicine Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Eshelman School Of Pharmacy and Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, 5034 Old Clinic Bldg, CB 7110, Chapel Hill, NC 27599, USA
    N C Med J 74:485-93. 2013
    ..Good evidence of clinical utility must be obtained before pharmacogenomic testing is widely implemented. ..
  2. pmc Methods for the drug effectiveness review project
    Marian S McDonagh
    Department of Medical Informatics and Clinical Epidemiology and Evidence based Practice Center, School of Medicine, Oregon Health and Science University, Portland, OR, USA
    BMC Med Res Methodol 12:140. 2012
    ..In addition, our on-going interactions with the policy-makers that use the reports are described...
  3. ncbi request reprint Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
    Daniel E Jonas
    University of North Carolina at Chapel Hill, Department of Medicine, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Ann Intern Med 157:645-54. 2012
    ..Alcohol misuse, which includes the full spectrum from risky drinking to alcohol dependence, is a leading cause of preventable death in the United States...
  4. doi request reprint Identifying priorities for patient-centered outcomes research for serious mental illness
    Daniel E Jonas
    Department of Medicine, University of North Carolina atChapel Hill, 5039 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Psychiatr Serv 63:1125-30. 2012
    ..The purpose of this project was to engage a diverse group of stakeholders (N=38) to help establish priorities to guide patient-centered outcomes research (PCOR) in serious mental illness...
  5. pmc Chapter 11: challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators
    Daniel E Jonas
    Department of Medicine, Cecil G Sheps Center for Health Services Research, and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Gen Intern Med 27:S83-93. 2012
    ..In addition, reviewers should note whether appropriate adjustments for multiple comparisons were used...
  6. doi request reprint Patient time requirements for anticoagulation therapy with warfarin
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, USA
    Med Decis Making 30:206-16. 2010
    ..Most patients receiving warfarin are managed in outpatient office settings or anticoagulation clinics that require frequent visits for monitoring...
  7. doi request reprint Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
    Health Econ 19:1193-211. 2010
    ..The screening colonoscopy process requires a considerable amount of time and some discomfort for patients...
  8. doi request reprint Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study
    Daniel E Jonas
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Med Decis Making 28:56-65. 2008
    ..The authors sought to estimate the amount and value of patient time required for screening colonoscopy...
  9. doi request reprint Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis
    Lea C Watson
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Prim Care Community Health 4:294-306. 2013
    ..Depression concomitant with chronic medical conditions is common and burdensome in primary care...
  10. ncbi request reprint Patient time requirements for screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 102:2401-10. 2007
    ..To measure the amount of time patients spend in the screening colonoscopy process...
  11. pmc Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials
    Gary N Asher
    Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Altern Complement Med 16:1097-108. 2010
    ..Our aim was to conduct a systematic review and meta-analysis of studies evaluating auriculotherapy for pain management...
  12. pmc Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Interv Aging 3:211-25. 2008
    ..63 and 1.42, respectively). Indirect comparisons also favored donepezil over galantamine with regard to behavior. Across trials, the incidence of adverse events was generally lowest for donepezil and highest for rivastigmine...
  13. doi request reprint Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial
    Daniel E Jonas
    Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Pharmacogenomics 14:1593-603. 2013
    ..This study aimed to assess the effectiveness of genotype-guided warfarin dosing...
  14. doi request reprint Interventions to prevent post-traumatic stress disorder: a systematic review
    Catherine A Forneris
    Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina 27599 7160, USA
    Am J Prev Med 44:635-50. 2013
    ..This review assessed the efficacy, comparative effectiveness, and harms of psychological, pharmacologic, and emerging interventions to prevent PTSD...
  15. doi request reprint Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care
    Tejinder K Rakhra-Burris
    UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7361, USA
    Pharmacogenomics 11:13-21. 2010
    ..IPIT Investigators are actively incorporating a pharmacogenomics curriculum into existing teaching programs at all levels...
  16. doi request reprint Future research needs for evaluating the integration of mental health and substance abuse treatment with primary care
    Timothy S Carey
    Carey, MORRISSEY, Jonas, Ellis, and WINES University of North Carolina Chapel Hill, Cecil G Sheps Center for Health Services Research, RTI UNC Evidence based Practice Center, Chapel Hill, NC CROTTY Hayes, Inc, Lansdale, PA THAKER, WOODELL, and VISWANATHAN Research Triangle Institute International, RTI UNC Evidence based Practice Center, Research Triangle Park, NC
    J Psychiatr Pract 19:345-59. 2013
    ....
  17. doi request reprint Quality of reporting on randomised controlled trials of auriculotherapy for pain
    Gary N Asher
    Department of Family Medicine, University of North Carolina, Chapel Hill, NC 27599 7595, USA
    Acupunct Med 29:122-6. 2011
    ....
  18. doi request reprint Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis
    Rishi J Desai
    Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA
    Ann Pharmacother 46:1491-505. 2012
    ..Very little information is available on comparative discontinuation rates of the biologics...
  19. pmc Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis
    Daniel J Crespin
    Department of Health Policy and Management, University of North Carolina, Chapel Hill, NC, USA
    Value Health 14:483-91. 2011
    ..In 2011, clopidogrel will lose its patent protection and likely will be substantially less expensive than ticagrelor...
  20. doi request reprint Genetic and clinical factors relating to warfarin dosing
    Daniel E Jonas
    University of North Carolina, Chapel Hill, 5039 Old Clinic Building, Campus Box 7110, Chapel Hill, NC 27599, USA
    Trends Pharmacol Sci 30:375-86. 2009
    ..Whether genotype-guided dosing is clinically beneficial remains unclear, but studies are currently underway that will help to determine this...
  21. doi request reprint How much time do adults spend on health-related self-care? Results from the American time use survey
    Daniel E Jonas
    University of North Carolina, Chapel Hill, Department of Medicine, Division of General Medicine, Chapel Hill, NC 27599, USA
    J Am Board Fam Med 24:380-90. 2011
    ..Objective: The aim of this study was to describe how much time American adults reported spending on health-related self-care (eg, taking insulin, dressing a wound)...